
    
      A multicenter, prospective, interventional, randomized-controlled trial. Randomization will
      be in a 1:1 ratio, Test Arm (PCI + Cooling) or Control Arm (PCI alone) in up to 468
      randomized subjects (234 subjects in each arm). Endpoint: Relative reduction of 20% in mean
      anterior myocardial infarct size as determined by Cardiac Magnetic Resonance (cMR) imaging at
      4-6 days post infarct in the Test Arm (cooling + PCI) relative to the Control Arm (PCI only).
    
  